131 related articles for article (PubMed ID: 38156654)
1. Differences in Management Between Dermatologists and Oncologists for Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
Oliel S; Bierbrier R; D'Aguanno K; Esfahani K; Pehr K
J Cutan Med Surg; 2024; 28(1):79-81. PubMed ID: 38156654
[No Abstract] [Full Text] [Related]
2. Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors.
Bierbrier R; Esfahani K; Pehr K
J Cutan Med Surg; 2022; 26(6):624-625. PubMed ID: 35980317
[No Abstract] [Full Text] [Related]
3. Reader Comment Regarding "Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors".
Fournier C; Sauder MB
J Cutan Med Surg; 2023; 27(3):294. PubMed ID: 36927192
[No Abstract] [Full Text] [Related]
4. An Analysis of Risk Factors for the Development of Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
Bierbrier R; D'Aguanno K; Oliel S; Zeng Y; Esfahani K; Pehr K
J Cutan Med Surg; 2023 Nov; 27(6):614-620. PubMed ID: 37942582
[TBL] [Abstract][Full Text] [Related]
5. Severe EGFR inhibitor-induced acneiform eruption responding to dapsone.
Beshay A; Petersen M; Rhoads JLW
Dermatol Online J; 2021 Jul; 27(7):. PubMed ID: 34391331
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of topical epidermal growth factor cream for patients with epidermal growth factor receptor inhibitor-induced acneiform eruption: a randomized controlled trial.
Lee JH; Ju HJ; Kwon HS; Jung HM; Kim GM; Bae JM; An HJ
Br J Dermatol; 2020 Jan; 182(1):219-221. PubMed ID: 31301244
[No Abstract] [Full Text] [Related]
7. Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.
Costello CM; Hill HE; Brumfiel CM; Yang YW; Swanson DL
J Am Acad Dermatol; 2021 Mar; 84(3):840-841. PubMed ID: 33039483
[No Abstract] [Full Text] [Related]
8. A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors.
Bierbrier R; Lam M; Pehr K
Dermatol Ther; 2022 May; 35(5):e15412. PubMed ID: 35220635
[TBL] [Abstract][Full Text] [Related]
9. Management of Dermatologic Complications of Lung Cancer Therapies.
Pugliese SB; Neal JW; Kwong BY
Curr Treat Options Oncol; 2015 Oct; 16(10):50. PubMed ID: 26338208
[TBL] [Abstract][Full Text] [Related]
10. Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers.
Magnino MZ; Perry DJ; Subramaniam DS; DeKlotz CMC
J Am Acad Dermatol; 2020 Feb; 82(2):486-488. PubMed ID: 31279812
[No Abstract] [Full Text] [Related]
11. Acneiform eruption induced by molecularly targeted agents in antineoplastic therapy: A review.
Yuan C; Wang B
J Cosmet Dermatol; 2023 Aug; 22(8):2150-2157. PubMed ID: 36924348
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for the development of acneiform eruptions in patients on epidermal growth factor receptor inhibitors.
Bierbrier R; D'Aguanno K; Kasymjanova G; Dell'Aniello S; Agulnik J; Pehr K
J Am Acad Dermatol; 2023 Apr; 88(4):869-870. PubMed ID: 36228936
[No Abstract] [Full Text] [Related]
13. EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects.
Recuero JK; Fitz JR; Pereira AA; Bonamigo RR
An Bras Dermatol; 2023; 98(4):429-439. PubMed ID: 36990917
[TBL] [Abstract][Full Text] [Related]
14. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Sheu J; Hawryluk EB; Litsas G; Thakuria M; LeBoeuf NR
Clin Breast Cancer; 2015 Feb; 15(1):e77-81. PubMed ID: 25445421
[No Abstract] [Full Text] [Related]
15. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
Requena C; Llombart B; Sanmartín O
Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
[TBL] [Abstract][Full Text] [Related]
16. Duration of Oral Antibiotics Administration for Cetuximab-Induced Acneiform Eruption.
Park JH; Choi Y; Kim HJ; Oh SJ; Lee DY; Lee JH; Lee JH
Dermatology; 2021; 237(3):457-463. PubMed ID: 33302268
[TBL] [Abstract][Full Text] [Related]
17. [Acneiform eruption from epidermal growth factor receptor inhibitors].
Martínez de Lagrán Z; Ratón JA; Lasa O; Acebo E; Díaz-Pérez JL
Actas Dermosifiliogr; 2005 Sep; 96(7):450-4. PubMed ID: 16476273
[TBL] [Abstract][Full Text] [Related]
18. Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions.
Chiang HC; Anadkat MJ
J Am Acad Dermatol; 2013 Oct; 69(4):657-8. PubMed ID: 24034378
[No Abstract] [Full Text] [Related]
19. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
Shin JU; Park JH; Cho BC; Lee JH
Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507
[TBL] [Abstract][Full Text] [Related]
20. A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.
Andrews ED; Garg N; Patel AB
J Am Acad Dermatol; 2020 Apr; 82(4):998-1000. PubMed ID: 31604105
[No Abstract] [Full Text] [Related]
[Next] [New Search]